相关实验视频

Updated: Jan 9, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

B 淋巴细胞有助于 ангиотензин II 诱导的心脏缩

Xiujuan Zhao¹, Xiaoyan Di², Hangli Wu²

¹Ultrasound Medical Center, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, People's Republic of China.

Scientific reports

|December 8, 2025

概括

B淋巴细胞通过产生CCL7来放大 ангиотензинII诱导的心脏缩,CCL7将单细胞招募到心脏中. 消除B细胞或CCL7可以减少这种炎症和心脏膨胀,而不依赖于血压.

科学领域:

心脏病学心脏病学
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

免疫反应在心肌损伤中至关重要.
乙淋巴细胞在 ангиотензин II 诱导的心脏缩中的作用尚不清楚.
乙细胞可以通过化学激素的产生和单细胞的招募促进心脏重塑.

研究的目的:

调查B淋巴细胞对 ангиотензинII诱导的心脏缩的贡献.
为了确定B细胞是否调节心脏中的化学激素产生和单细胞透.
探索B细胞介导炎症作为高血压心脏病的治疗点.

主要方法:

野生型和B细胞缺乏的小鼠注入了 ангиотензин II.
评估心脏重塑和炎症,使用血压测量,心声学,流细胞计和组织病理学.
对B细胞特异性CCL7缺陷影响的评估.

主要成果:

ангиотензин II 治疗诱导 B 淋巴细胞产生 CCL7,增强单细胞招募到心肌.
B细胞缺陷或CCL7缺陷减弱了 ангиотензинII诱导的心脏缩和炎症.
尽管所有组的血压反应相似,但观察到这些影响.

结论:

乙淋巴细胞通过CCL7的产生和随后的单细胞招募,严重放大 ангиотензинII诱导的心脏缩.
这种依赖B细胞的机制独立于高血压.
针对B细胞介导炎症为高血压心脏病提供了潜在的治疗策略.

关键词:

ангиотензин II 的使用.这就是B型淋巴细胞.过度缩过度缩过度缩

更多相关视频

Intracellular Staining and Flow Cytometry to Identify Lymphocyte Subsets within Murine Aorta, Kidney and Lymph Nodes in a Model of Hypertension

Intracellular Staining and Flow Cytometry to Identify Lymphocyte Subsets within Murine Aorta, Kidney and Lymph Nodes in a Model of Hypertension

Published on: January 28, 2017

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

相关概念视频

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

Antihypertensive Drugs: Action of β1 Blockers

Antihypertensive Drugs: Action of β₁ Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...